The Toansa plant is crucial for Ranbaxy as about 70% of APIs used in its formulations are said to be manufactured there.

The $500 million fine on Ranbaxy, for violating drug manufacturing norms is "a wake up call" for Indian pharmaceutical industry.

Drug major Ranbaxy Laboratories said it has hired two US-based consultants to advise it on remedial work to be done at its manufacturing un...

The decree is unprecedented in its scope, and requires the drug maker to take a range of actions to correct its violations and ensure they ...

Ranbaxy has reached an agreement with the US health regulator to lift a ban on import of drugs from its certain factories in India.

US-based Watson Pharmaceuticals said it has launched in US market the generic version of cholesterol lowering drug Lipitor following the ex...

Settling the issue is of immense importance to Ranbaxy as it is the first firm to file an abbreviated new drug application to launch a gene...

RANBAXY Laboratories has sought the US drug regulator’s approval to sell a new drug in the world’s largest pharma market that has been manu...

Ranbaxy Laboratories has sought the US drug regulator’s approval to sell a new drug in the world’s largest pharma market that has been manu...

Ranbaxy’s Japanese parent Daiichi Sankyo has set up a new firm, Daiichi Sankyo Espha Company (DSECL) for marketing generic drugs in Japan.

Ranbaxy Laboratories and its Japanese parent Daiichi Sankyo's proposal to unveil a three-year plan for exploiting synergies in operations t...

India’s largest drug company Ranbaxy said the US drug regulator’s decision to halt approval of drugs from one of its plants in India will a...

To address falsified data, FDA has invoked its Application Integrity Policy (AIP) against Paonta Sahib facility. Factors for successful M&A...

The case is related to alleged falsification of records by Ranbaxy that resulted in sale of generic drugs in US which did not meet the stan...

Sources said that USFDA has given a ‘not approved’ rating to new products manufactured at the facility, although this could not be independ...